SNHG3 and hepatocellular carcinoma: Wu et al.’s (2019) research found that SNHG3 can target miR-139-5p to regulate the expression of BMI1, thereby promoting the migration, invasion, and proliferation of liver cancer cells. Zhang et al.’s (2019) study found that SNHG3 induces epithelial-mesenchymal transition and resistance to sorafenib by regulating the miR-128/CD151 pathway in HCC.